Late Infections Seen With Rituxan in Vasculitis

LIVERPOOL--Treatment of vasculitis associated with antineutrophil cytoplasmic antibodies (ANCA) with rituximab (Rituxan) is known to be effective, but in a U.K. cohort was associated with an increase in late-onset infections, a researcher reported here. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1lE8lV5